CSIT to Open Maternal and Infant Health R&D Seed Grant Program Applications on July 1
Program Dedicates $750,000 in Grant Funding to New Jersey-Based Early-Stage Innovation Companies to Tackle Maternal & Infant Health Challenges
Trenton, N.J. (June 30, 2022) – The New Jersey Commission on Science, Innovation, and Technology (CSIT) will open applications for its $750,000 Maternal and Infant Health Research and Development (R&D) Seed Grant Program on Friday, July 1. The application will be available at https://www.njeda.gov/maternal-and-infant-health-grant.
Through the Maternal and Infant R&D Seed Grant Program, CSIT will award 10 grants of up to $75,000 each to help New Jersey-based early-stage innovation-based companies accelerate the development of technologies, products, and services that support pregnant women and new mothers. Specifically, the Maternal and Infant Health R&D Seed Grant Program will support investments in R&D and new technologies supporting maternal and infant health in targeted sectors including life sciences, technology, and non-retail food and beverage.
With the Maternal and Infant Health R&D Seed Grant Program, CSIT will advance the innovation economy through the development of critically necessary research, products, and services designed to enhance maternal and infant health. This effort supports the goals established by the Nurture NJ Strategic Plan, which aims to make New Jersey the safest place in America to deliver a baby, specifically focusing on ending racial disparities in maternal and infant health outcomes. Launched in 2019 by Governor Phil Murphy and First Lady Tammy Murphy, Nurture NJ is a comprehensive, whole-of-government effort to reduce maternal and infant mortality and morbidity and ensure equitable care among women and children of all races and ethnicities in New Jersey.
In order to be eligible, applicants must be authorized and in good standing to conduct business in New Jersey, must have $1 million or less in 2021 calendar year sales revenue, and must have 25 or fewer full-time equivalent workers. Complete eligibility requirements can be found at https://www.njeda.gov/maternal-and-infant-health-grant. Applications from businesses located in an Opportunity Zone-eligible census tract or a Government Restricted Municipality (Atlantic City, Paterson, or Trenton), or businesses that are minority-, woman-, or veteran-owned are all eligible for bonus points with respect to the scoring criteria.
CSIT hosted an information session about the new grant program earlier this week. A recording of that session is available on CSIT’s website www.njeda.gov/csit.
CSIT signed an agreement last month with the New Jersey Economic Development Authority (NJEDA) whereby the NJEDA will dedicate $250,000 from the Economic Recovery Fund towards this program and CSIT will provide the remainder of the funding from its current budget.
About the New Jersey CSIT
In August 2018, Governor Murphy signed legislation re-establishing the former New Jersey Commission on Science and Technology as the CSIT. Comprised of representatives from the public and private sectors, as well as academia, the Commission is tasked with leading the way in promoting the state as a home for academic and technological research, development, and commercialization.
About the NJEDA
The New Jersey Economic Development Authority (NJEDA) serves as the State’s principal agency for driving economic growth. The NJEDA is committed to making New Jersey a national model for inclusive and sustainable economic development by focusing on key strategies to help build strong and dynamic communities, create good jobs for New Jersey residents, and provide pathways to a stronger and fairer economy. Through partnerships with a diverse range of stakeholders, the NJEDA creates and implements initiatives to enhance the economic vitality and quality of life in the State and strengthen New Jersey’s long-term economic competitiveness.
To learn more about state resources available to New Jersey entrepreneurs and early-stage companies, visit https://www.njeda.gov and follow @NewJerseyEDA on Facebook, Twitter, Instagram, and LinkedIn.
###
Related Content
September 17, 2024
NOTICE OF CCRC BOARD MEETING
Please be advised that the next Capital City Redevelopment Corporation Board Meeting will be held in person and via teleconference on Tuesday, September 24, 2024, at 12:00 pm.
September 13, 2024
NJEDA Board Approves NJ Innovation Evergreen Fund Investment into Princeton-Based Life Sciences Company
TRENTON, N.J. (September 13, 2024) – This week, the New Jersey Economic Development Authority (NJEDA) Board approved the fourth investment from the New Jersey Innovation Evergreen Fund (NJIEF) into an emerging Princeton-based life sciences company, RICOVR Healthcare, which is developing a rapid diagnostic test for cannabis use.
September 13, 2024
NJEDA Board Awards Tax Credits to Assist Rehabilitation of Historic Schwehm Building in Atlantic City
TRENTON, N.J. (September 13, 2024) – Earlier this week, the New Jersey Economic Development Authority (NJEDA) Board approved a tax credit award of up to $8 million to rehabilitate the underutilized Schwehm Building in downtown Atlantic City under the Historic Property Reinvestment Program (HPRP).